The N-terminal RASSF family: a new group of Ras-association-domain-containing proteins, with emerging links to cancer formation

被引:78
作者
Sherwood, Victoria [1 ]
Recino, Asha [1 ]
Jeffries, Alex [1 ]
Ward, Andrew [1 ]
Chalmers, Andrew D. [1 ]
机构
[1] Univ Bath, Dept Biol & Biochem, Ctr Regenerat Med, Bath BA2 7AY, Avon, England
基金
英国医学研究理事会;
关键词
N-terminal Ras-association domain family (RASSF7-10); tumour suppressor; ubiquitin fold; TUMOR-SUPPRESSOR RASSF1A; GENE-EXPRESSION; MICROTUBULE STABILITY; SUSCEPTIBILITY LOCUS; BINDING-PROTEIN; PAS1; LOCUS; LUNG; IDENTIFICATION; KINASE; BREAST;
D O I
10.1042/BJ20091318
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The RASSF (Ras-association domain family) has recently gained several new members and now contains ten proteins (RASSF1-10), several of which are potential tumour suppressors. The family can be split into two groups, the classical RASSF proteins (RASSF1-6) and the four recently added N-terminal RASSF proteins (RASSF7-10). The N-terminal RASSF proteins have a number of differences from the classical RASSF members and represent a newly defined set of potential Ras effectors. They have been linked to key biological processes, including cell death, proliferation, microtubule stability, promoter methylation, vesicle trafficking and response to hypoxia. Two members of the N-terminal RASSF family have also been highlighted as potential tumour suppressors. The present review will summarize what is known about the N-terminal RASSF proteins, addressing their function and possible links to cancer formation. It will also compare the N-terminal RASSF proteins with the classical RASSF proteins and ask whether the N-terminal RASSF proteins should be considered as genuine members or imposters in the RASSF family.
引用
收藏
页码:303 / 311
页数:9
相关论文
共 106 条
[1]   Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours [J].
Agathanggelou, A ;
Honorio, S ;
Macartney, DP ;
Martinez, A ;
Dallol, A ;
Radar, J ;
Fullwood, P ;
Chauhan, A ;
Walker, R ;
Shaw, JA ;
Hosoe, S ;
Lerman, MI ;
Minna, JD ;
Maher, ER ;
Latif, F .
ONCOGENE, 2001, 20 (12) :1509-1518
[2]   Transcriptional regulation of cyclin A2 by RASSF1A through the enhanced binding of p120E4F to the cyclin A2 promoter [J].
Ahmed-Choudhury, J ;
Agathanggelou, A ;
Fenton, SL ;
Ricketts, C ;
Clark, GJ ;
Maher, ER ;
Latif, F .
CANCER RESEARCH, 2005, 65 (07) :2690-2697
[3]   Novel proteins that interact with the COOH-terminal cytosolic routing determinants of an integral membrane peptide-processing enzyme [J].
Alam, MR ;
Caldwell, BD ;
Johnson, RC ;
Darlington, DN ;
Mains, RE ;
Eipper, BA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (45) :28636-28640
[4]   RASSF6 is a novel member of the RASSF family of tumor suppressors [J].
Allen, N. P. C. ;
Donninger, H. ;
Vos, M. D. ;
Eckfeld, K. ;
Hesson, L. ;
Gordon, L. ;
Birrer, M. J. ;
Latif, F. ;
Clark, G. J. .
ONCOGENE, 2007, 26 (42) :6203-6211
[5]   Rassf Family of Tumor Suppressor Polypeptides [J].
Avruch, Joseph ;
Xavier, Ramnik ;
Bardeesy, Nabeel ;
Zhang, Xian-Feng ;
Praskova, Maria ;
Zhou, Dawang ;
Xia, Fan .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (17) :11001-11005
[6]   The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to bax conformational change and cell death [J].
Baksh, S ;
Tommasi, S ;
Fenton, S ;
Yu, VC ;
Martins, LM ;
Pfeifer, GP ;
Latif, F ;
Downward, J ;
Neel, BG .
MOLECULAR CELL, 2005, 18 (06) :637-650
[7]   DNA Microarray analysis of pancreatic malignancies [J].
Brandt, R ;
Grützmann, R ;
Bauer, A ;
Jesnowski, R ;
Ringel, J ;
Löhr, M ;
Pilarsky, C ;
Hoheisel, JD .
PANCREATOLOGY, 2004, 4 (06) :587-597
[8]   Ubiquitous activation of Ras and Jak/Stat pathways in human HCC [J].
Calvisi, DF ;
Ladu, S ;
Gorden, A ;
Farina, M ;
Conner, EA ;
Lee, JS ;
Factor, VM ;
Thorgeirsson, SS .
GASTROENTEROLOGY, 2006, 130 (04) :1117-1128
[9]   NORE1A Tumor Suppressor Candidate Modulates p21CIP1 via p53 [J].
Calvisi, Diego F. ;
Donninger, Howard ;
Vos, Michele D. ;
Birrer, Michael J. ;
Gordon, Laura ;
Leaner, Virna ;
Clark, Geoffrey J. .
CANCER RESEARCH, 2009, 69 (11) :4629-4637
[10]   hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer [J].
Camps, Carme ;
Buffa, Francesca M. ;
Colella, Stefano ;
Moore, John ;
Sotiriou, Christos ;
Sheldon, Helen ;
Harris, Adrian L. ;
Gleadle, Jonathan M. ;
Ragoussis, Jiannis .
CLINICAL CANCER RESEARCH, 2008, 14 (05) :1340-1348